Reconstituted lipoprotein: A versatile class of biologically-inspired nanostructures

ACS Nano

Volumn 5, Issue 1, 2011, Pages 42-57

  Bricarello, Daniel A ^a   Smilowitz, Jennifer T ^a   Zivkovic, Angela M ^a   German, J Bruce ^a   Parikh, Atul N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bionanotechnology; Drug delivery; Energy harvesting; HDL; Infectious disease; Lipoprotein; Membrane proteins; Nanoparticles; Protein structure

Indexed keywords

BIONANOTECHNOLOGY; HDL; INFECTIOUS DISEASE; LIPOPROTEIN; MEMBRANE PROTEINS; PROTEIN STRUCTURE;

BIOMIMETICS; DRUG DELIVERY; ENERGY CONVERSION; ENERGY HARVESTING; LIPID BILAYERS; MONOLAYERS; NANOSTRUCTURES; PHOSPHOLIPIDS; SCAFFOLDS (BIOLOGY); SIGNAL TRANSDUCTION;

PROTEINS;

BIOMIMETIC MATERIAL; DRUG CARRIER; LIPOPROTEIN; NANOMATERIAL;

ANIMAL; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR IMAGING; REVIEW;

ANIMALS; BIOMIMETIC MATERIALS; DRUG CARRIERS; HUMANS; LIPOPROTEINS; MOLECULAR IMAGING; NANOSTRUCTURES;

EID: 79955116128     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn103098m     Document Type: Review

References (138)

1. Segré , D.; Ben-Eli, D.; Deamer, D.; Lancet, D. The Lipid World. Origins Life Evol. Biospheres 2001, 31, 119-145. (Pubitemid 32219178)
2. Szostak, J.; Bartel, D.; Luisi, P. Synthesizing Life. Nature 2001, 409, 387-390. (Pubitemid 32151251)
3. Bachmann, P.; Luisi, P.; Lang, J. Autocatalytic Self-Replicating Micelles as Models for Prebiotic Structures. Nature 1992, 357, 57-59.
4. Deamer, D. The First Living Systems: A Bioenergetic Perspective. Microbiol. Mol. Biol. Rev. 1997, 61, 239-261. (Pubitemid 27283802)
5. Mulkidjanian, A.; Galperin, M.; Koonin, E. Co-evolution of Primordial Membranes and Membrane Proteins. Trends Biochem. Sci. 2009, 34, 206-215.
6. Barker, W.; Dayhoff, M. Evolution of Lipoproteins Deduced from Protein Sequence Data. Comp. Biochem. Physiol., Part B 1977, 57, 309-315. (Pubitemid 8146619)
7. Mahley, R.; Innerarity, T.; Rall Jr, S.; Weisgraber, K. Plasma Lipoproteins: Apolipoprotein Structure and Function. J. Lipid Res. 1984, 25, 1277-1294. (Pubitemid 15150638)
8. Karathanasis, S. Apolipoprotein Multigene Family: Tandem Organization of Human Apolipoprotein AI, CIII, and AIV Genes. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 6374-6378. (Pubitemid 16230515)
9. Kaess, B.; Fischer, M.; Baessler, A.; Stark, K.; Huber, F.; Kremer, W.; Kalbitzer, H.; Schunkert, H.; Riegger, G.; Hengstenberg, C. The Lipoprotein Subfraction Profile: Heritability and Identification of Quantitative Trait Loci. J. Lipid Res. 2008, 49, 715-723.
10. Ikonen, E. Cellular Cholesterol Trafficking and Compartmentalization. Nat. Rev. Mol. Cell Biol. 2008, 9, 125-138. (Pubitemid 351158918)
11. Linsel-Nitschke, P.; Tall, A. HDL as a Target in the Treatment of Atherosclerotic Cardiovascular Disease. Nat. Rev. Drug Discovery 2005, 4, 193-205. (Pubitemid 40372554)
12. German, J.; Smilowitz, J.; Zivkovic, A. Lipoproteins: When Size Really Matters. Curr. Opin. Colloid Interface Sci. 2006, 11, 171-183. (Pubitemid 43867394)
13. Katz, E.; Willner, I. Integrated Nanoparticle-Biomolecule Hybrid Systems: Synthesis, Properties, and Applications. Angew. Chem., Int. Ed. 2004, 43, 6042-6108. (Pubitemid 39611873)
14. Sarikaya, M.; Tamerler, C.; Alex, K.; Schulten, K.; Baneyx, F. Molecular Biomimetics: Nanotechnology through Biology. Nat. Mater. 2003, 2, 577-585.
15. Zhang, S. Fabrication of Novel Biomaterials through Molecular Self-Assembly. Nat. Biotechnol. 2003, 21, 1171-1178. (Pubitemid 37186173)
16. Luzzati, V.; Tardieu, A.; Gulik-Krzywicki, T. Polymorphism of Lipids. Nature 1968, 217, 1028-1030.
17. Barauskas, J.; Johnsson, M.; Tiberg, F. Self-Assembled Lipid Superstructures: Beyond Vesicles and Liposomes. Nano Lett. 2005, 5, 1615-1619. (Pubitemid 41251697)
18. Drummond, C.; Fong, C. Surfactant Self-Assembly Objects as Novel Drug Delivery Vehicles. Curr. Opin. Colloid Interface Sci. 1999, 4, 449-456. (Pubitemid 30449773)
19. Scanu, A. Binding of Human Serum High Density Lipoprotein Apoprotein with Aqueous Dispersions of Phospholipids. J. Biol. Chem. 1967, 242, 711-719.
20. Scanu, A.; Cump, E.; Toth, J.; Koga, S.; Stiller, E.; Albers, L. Degradation and Reassembly of a Human Serum High-Density Lipoprotein. Evidence for Differences in Lipid Affinity among Three Classes of Polypeptide Chains. Biochemistry 1970, 9, 1327-1335.
21. Forte, T.; Norum, K.; Glomset, J.; Nichols, A. Plasma Lipoproteins in Familial Lecithin: Cholesterol Acyltransferase Deficiency: Structure of Low and High Density Lipoproteins as Revealed by Electron Microscopy. J. Clin. Invest. 1971, 50, 1141-1148.
22. Jonas, A. Reconstitution of High-Density Lipoproteins. Methods Enzymol. 1986, 128, 553-582. (Pubitemid 16100916)
23. Wu, Z.; Wagner, M.; Zheng, L.; Parks, J.; Shy, J.; Smith, J.; Gogonea, V.; Hazen, S. The Refined Structure of Nascent HDL Reveals a Key Functional Domain for Particle Maturation and Dysfunction. Nat. Struct. Mol. Biol. 2007, 14, 861-868. (Pubitemid 47373831)
24. Fukuda, M.; Nakano, M.; Miyazaki, M.; Handa, T. Thermodynamic and Kinetic Stability of Discoidal High-Density Lipoprotein Formation from Phosphatidylcholine/ Apolipoprotein AI Mixture. J. Phys. Chem. B 2010, 114, 8228-8234.
25. Thomas, M.; Bhat, S.; Sorci-Thomas, M. Three-Dimensional Models of HDL APOA-I: Implications for Its Assembly and Function. J. Lipid Res. 2008, 49, 1875-1883.
26. Shaw, A.; McLean, M.; Sligar, S. Phospholipid Phase Transitions in Homogeneous Nanometer Scale Bilayer Discs. FEBS Lett. 2004, 556, 260-264. (Pubitemid 38058589)
27. Fukuda, M.; Nakano, M.; Sriwongsitanont, S.; Ueno, M.; Kuroda, Y.; Handa, T. Spontaneous Reconstitution of Discoidal HDL from Sphingomyelin-Containing Model Membranes by Apolipoprotein AI. J. Lipid Res. 2007, 48, 882-889. (Pubitemid 46557893)
28. Tricerri, M.; Toledo, J.; Sanchez, S.; Hazlett, T.; Gratton, E.; Jonas, A.; Garda, H. Visualization and Analysis of Apolipoprotein AI Interaction with Binary Phospholipid Bilayers. J. Lipid Res. 2005, 46, 669-678. (Pubitemid 43073276)
29. Mouritsen, O. Theoretical Models of Phospholipid Phase Transitions. Chem. Phys. Lipids 1991, 57, 179-194.
30. Mouritsen, O.; Jørgensen, K. Dynamical Order and Disorder in Lipid Bilayers. Chem. Phys. Lipids 1994, 73, 3-25. (Pubitemid 24299185)
31. Segrest, J.; Jones, M.; Klon, A.; Sheldahl, C.; Hellinger, M.; De Loof, H.; Harvey, S. A Detailed Molecular Belt Model for Apolipoprotein AI in Discoidal High Density Lipoprotein. J. Biol. Chem. 1999, 274, 31755-31758.
32. Martin, D.; Budamagunta, M.; Ryan, R.; Voss, J.; Oda, M. Apolipoprotein AI Assumes a Ìlooped Beltî Conformation on Reconstituted High Density Lipoprotein. J. Biol. Chem. 2006, 281, 20418-20426. (Pubitemid 44065815)
33. Chromy, B.; Arroyo, E.; Blanchette, C.; Bench, G.; Benner, H.; Cappuccio, J.; Coleman, M.; Henderson, P.; Hinz, A.; Kuhn, E. Different Apolipoproteins Impact Nanolipoprotein Particle Formation. J. Am. Chem. Soc. 2007, 129, 14348-14354. (Pubitemid 350171458)
34. Bolanos-Garcia, V.; Miguel, R. On the Structure and Function of Apolipoproteins: More Than a Family of Lipid-Binding Proteins. Prog. Biophys. Mol. Biol. 2003, 83, 47-68. (Pubitemid 36572978)
35. Bayburt, T.; Grinkova, Y.; Sligar, S. Self-Assembly of Discoidal Phospholipid Bilayer Nanoparticles with Membrane Scaffold Proteins. Nano Lett. 2002, 2, 853-856. (Pubitemid 135706448)
36. Borhani, D.; Rogers, D.; Engler, J.; Brouillette, C. Crystal Structure of Truncated Human Apolipoprotein AI Suggests a Lipid-Bound Conformation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 12291-12296. (Pubitemid 27492521)
37. Denisov, I.; Grinkova, Y.; Lazarides, A.; Sligar, S. Directed Self-Assembly of Monodisperse Phospholipid Bilayer Nanodiscs with Controlled Size. J. Am. Chem. Soc. 2004, 126, 3477-3487. (Pubitemid 38366738)
38. Walter, A.; Vinson, P.; Kaplun, A.; Talmon, Y. Intermediate Structures in the Cholate-Phosphatidylcholine Vesicle-Micelle Transition. Biophys. J. 1991, 60, 1315-1325.
39. Baker, S.; Hopkins, R.; Blanchette, C.; Walsworth, V.; Sumbad, R.; Fischer, N.; Kuhn, E.; Coleman, M.; Chromy, B.; Le tant, S. Hydrogen Production by a Hyperthermophilic Membrane-Bound Hydrogenase in Water-Soluble Nanolipoprotein Particles. J. Am. Chem. Soc. 2009, 131, 7508-7509.
40. Cappuccio, J.; Hinz, A.; Kuhn, E.; Fletcher, J.; Arroyo, E.; Henderson, P.; Blanchette, C.; Walsworth, V.; Corzett, M.; Law, R. Cell-Free Expression for Nanolipoprotein Particles: Building a High-Throughput Membrane Protein Solubility Platform. Methods Mol. Biol. 2009, 498, 273-296.
41. Katzen, F.; Fletcher, J.; Yang, J.; Kang, D.; Peterson, T.; Cappuccio, J.; Blanchette, C.; Sulchek, T.; Chromy, B.; Hoeprich, P. Insertion of Membrane Proteins into Discoidal Membranes Using a Cell-Free Protein Expression Approach. J. Proteome Res. 2008, 7, 3535-3542.
42. Banerjee, S.; Huber, T.; Sakmar, T. Rapid Incorporation of Functional Rhodopsin into Nanoscale Apolipoprotein Bound Bilayer (Nabb) Particles. J. Mol. Biol. 2008, 377, 1067-1081.
43. Shih, A.; Arkhipov, A.; Freddolino, P.; Schulten, K. Coarse Grained Protein-Lipid Model with Application to Lipoprotein Particles. J. Phys. Chem. B 2006, 110, 3674-3684.
44. Bayburt, T.; Carlson, J.; Sligar, S. Reconstitution and Imaging of a Membrane Protein in a Nanometer-Size Phospholipid Bilayer. J. Struct. Biol. 1998, 123, 37-44. (Pubitemid 28487843)
45. 2-Adrenergic Receptors Utilizing Self-Assembling Nanodisc Technology. BioTechniques 2006, 40, 601-610.
46. Bayburt, T.; Grinkova, Y.; Sligar, S. Assembly of Single Bacteriorhodopsin Trimers in Bilayer Nanodiscs. Archives of Biochem. Biophys. 2006, 450, 215-222. (Pubitemid 43849624)
47. Popot, J. Amphipols, Nanodiscs, and Fluorinated Surfactants: Three Nonconventional Approaches to Studying Membrane Proteins in Aqueous Solutions. Annu. Rev. Biochem. 2010, 79, 737-775.
48. Baas, B.; Denisov, I.; Sligar, S. Homotropic Cooperativity of Monomeric Cytochrome P450 3A4 in a Nanoscale Native Bilayer Environment. Arch. Biochem. Biophys. 2004, 430, 218-228. (Pubitemid 39208969)
49. Bayburt, T.; Leitz, A.; Xie, G.; Oprian, D.; Sligar, S. Transducin Activation by Nanoscale Lipid Bilayers Containing One and Two Rhodopsins. J. Biol. Chem. 2007, 282, 14875-14881. (Pubitemid 47093370)
50. Tsukamoto, H.; Sinha, A.; DeWitt, M.; Farrens, D. Monomeric Rhodopsin Is the Minimal Functional Unit Required for Arrestin Binding. J. Mol. Biol. 2010, 399, 501-511.
51. Wang, H.; Na, B.; Yang, H.; Tai, P. Additional in Vitro and in Vivo Evidence for SecA Functioning as Dimers in the Membrane: Dissociation into Monomers Is Not Essential for Protein Translocation in Escherichia Coli. J. Bacteriol. 2008, 190, 1413-1418. (Pubitemid 351215024)
52. Borch, J.; Hamann, T. The Nanodisc: A Novel Tool for Membrane Protein Studies. Biol. Chem. 2009, 390, 805-814.
53. Nath, A.; Atkins, W.; Sligar, S. Applications of Phospholipid Bilayer Nanodiscs in the Study of Membranes and Membrane Proteins. Biochemistry 2007, 46, 2059-2069. (Pubitemid 46355317)
54. Raschle, T.; Hiller, S.; Etzkorn, M.; Wagner, G. Nonmicellar Systems for Solution NMR Spectroscopy of Membrane Proteins. Curr. Opin. Struct. Biol. 2010, 20, 471-479.
55. Lyukmanova, E.; Shenkarev, Z.; Paramonov, A.; Sobol, A.; Ovchinnikova, T.; Chupin, V.; Kirpichnikov, M.; Blommers, M.; Arseniev, A. Lipid-Protein Nanoscale Bilayers: A Versatile Medium for NMR Investigations of Membrane Proteins and Membrane-Active Peptides. J. Am. Chem. Soc. 2008, 130, 2140-2141. (Pubitemid 351287974)
56. Gluck, J.; Wittlich, M.; Feuerstein, S.; Hoffmann, S.; Willbold, D.; Koenig, B. Integral Membrane Proteins in Nanodiscs Can Be Studied by Solution NMR Spectroscopy. J. Am. Chem. Soc. 2009, 131, 12060-12061.
57. Shenkarev, Z.; Lyukmanova, E.; Paramonov, A.; Shingarova, L.; Chupin, V.; Kirpichnikov, M.; Blommers, M.; Arseniev, A. Lipid-Protein Nanodiscs as Reference Medium in Detergent Screening for High-Resolution NMR Studies of Integral Membrane Proteins. J. Am. Chem. Soc. 2010, 132, 5628-5629.
58. Yoshiura, C.; Kofuku, Y.; Ueda, T.; Mase, Y.; Yokogawa, M.; Osawa, M.; Terashima, Y.; Matsushima, K.; Shimada, I. NMR Analyses of the Interaction between CCR5 and Its Ligand Using Functional Reconstitution of CCR5 in Lipid Bilayers. J. Am. Chem. Soc. 2010, 132, 6768-6777.
59. Carlson, J.; Jonas, A.; Sligar, S. Imaging and Manipulation of High-Density Lipoproteins. Biophys. J. 1997, 73, 1184-1189. (Pubitemid 27360707)
60. Malmsten, M.; Siegel, G.; Wood, W. Ellipsometry Studies of Lipoprotein Adsorption. J. Colloid Interface Sci. 2000, 224, 338-346. (Pubitemid 30215139)
61. Vinchurkar, M.; Bricarello, D.; Lagerstedt, J.; Buban, J.; Stahlberg, H.; Oda, M.; Voss, J.; Parikh, A. Bridging across Length Scales: Multiscale Ordering of Supported Lipid Bilayers via Lipoprotein Self-Assembly and Surface Patterning. J. Am. Chem. Soc. 2008, 130, 11164-11169.
62. Bricarello, D.; Mills, E.; Petrlova, J.; Voss, J.; Parikh, A. Ganglioside Embedded in Reconstituted Lipoprotein Binds Cholera Toxin with Elevated Affinity. J. Lipid Res. 2010, 51, 2731-2738.
63. Borch, J.; Torta, F.; Sligar, S.; Roepstorff, P. Nanodiscs for Immobilization of Lipid Bilayers and Membrane Receptors: Kinetic Analysis of Cholera Toxin Binding to a Glycolipid Receptor. Anal. Chem. 2008, 80, 6245-6252.
64. Fischer, N.; Blanchette, C.; Chromy, B.; Kuhn, E.; Segelke, B.; Corzett, M.; Bench, G.; Mason, P.; Hoeprich, P. Immobilization of His-Tagged Proteins on Nickel-Chelating Nanolipoprotein Particles. Bioconjugate Chem. 2009, 20, 460-465.
65. Marin, V.; Bayburt, T.; Sligar, S.; Mrksich, M. Functional Assays of Membrane-Bound Proteins with Samdi-TOF Mass Spectrometry. Angew. Chem., Int. Ed. 2007, 46, 8796-8798. (Pubitemid 350207929)
66. Zaitseva, E.; Saavedra, M.; Banerjee, S.; Sakmar, T.; Vogel, R. Seira Spectroscopy on a Membrane Receptor Monolayer Using Lipoprotein Particles as Carriers. Biophys. J. 2010, 99, 2327-2335.
67. Morrissey, J.; Pureza, V.; Davis-Harrison, R.; Sligar, S.; Ohkubo, Y.; Tajkhorshid, E. Blood Clotting Reactions on Nanoscale Phospholipid Bilayers. Thromb. Res. 2008, 122, S23-S26.
68. Shi, J.; Yang, T.; Kataoka, S.; Zhang, Y.; Diaz, A.; Cremer, P. GM1 Clustering Inhibits Cholera Toxin Binding in Supported Phospholipid Membranes. J. Am. Chem. Soc. 2007, 129, 5954-5961. (Pubitemid 46748502)
69. Wang, R.; Shi, J.; Parikh, A.; Shreve, A.; Chen, L.; Swanson, B. Evidence for Cholera Aggregation on GM1-Decorated Lipid Bilayers. Colloids Surf., B 2004, 33, 45-51. (Pubitemid 38050063)
70. Ermler, U.; Fritzsch, G.; Buchanan, S.; Michel, H. Structure of the Photosynthetic Reaction Centre from Rhodobacter Sphaeroides at 2.65 Å Resolution: Cofactors and Protein-Cofactor Interactions. Structure 1994, 2, 925-936.
71. Pebay-Peyroula, E.; Rummel, G.; Rosenbusch, J.; Landau, E. X-Ray Structure of Bacteriorhodopsin at 2.5 Angstroms from Microcrystals Grown in Lipidic Cubic Phases. Science 1997, 277, 1676-1681. (Pubitemid 27446232)
72. Zouni, A.; Witt, H.; Kern, J.; Fromme, P.; Krauss, N.; Saenger, W.; Orth, P. Crystal Structure of Photosystem II from Synechococcus Elongatus at 3.8 Å Resolution. Nature 2001, 409, 739-743. (Pubitemid 32144521)
73. Laible, P.; Scott, H.; Henry, L.; Hanson, D. Towards Higher-Throughput Membrane Protein Production for Structural Genomics Initiatives. J. Struct. Funct. Genom. 2004, 5, 167-172. (Pubitemid 39030632)
74. Graff, R.; Swanson, T.; Strano, M. Synthesis of Nickel-Nitrilotriacetic Acid Coupled Single-Walled Carbon Nanotubes for Directed Self-Assembly with Polyhistidine-Tagged Proteins. Chem. Mater. 2008, 20, 1824-1829. (Pubitemid 351560843)
75. Ham, M.; Choi, J.; Boghossian, A.; Jeng, E.; Graff, R.; Heller, D.; Chang, A.; Mattis, A.; Bayburt, T.; Grinkova, Y.; et al. Photoelectrochemical Complexes for Solar Energy Conversion That Chemically and Autonomously Regenerate. Nat. Chem. 2010, 2, 929-936.
76. Denisov, I.; Sligar, S. Cytochromes P450 in Nanodiscs. Biochim. Biophys. Acta 2010, 1814, 223-229.
77. Wacher, V.; Wu, C.; Benet, L. Overlapping Substrate Specificities and Tissue Distribution of Cytochrome P450 3A and P-Glycoprotein: Implications for Drug Delivery and Activity in Cancer Chemotherapy. Mol. Carcinog. 1995, 13, 129-134.
78. Shiflett, A. M.; Bishop, J. R.; Pahwa, A.; Hajduk, S. L. Human High Density Lipoproteins Are Platforms for the Assembly of Multicomponent Innate Immune Complexes. J. Biol. Chem. 2005, 280, 32578-32585. (Pubitemid 41368299)
79. Holmgren, J.; Lonnroth, I.; Svennerholm, L. Tissue Receptor for Cholera Exotoxin: Postulated Structure from Studies with GM1 Ganglioside and Related Glycolipids. Infect. Immun. 1973, 8, 208-214.
80. Harouse, J.; Bhat, S.; Spitalnik, S.; Laughlin, M.; Stefano, K.; Silberberg, D.; Gonzalez-Scarano, F. Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies against Galactosyl Ceramide. Science 1991, 253, 320-323. (Pubitemid 21917158)
81. Suzuki, Y.; Nagao, Y.; Kato, H.; Matsumoto, M.; Nerome, K.; Nakajima, K.; Nobusawa, E. Human Influenza A Virus Hemagglutinin Distinguishes Sialyloligosaccharides in Membrane-Associated Gangliosides as Its Receptor Which Mediates the Adsorption and Fusion Processes of Virus Infection. Specificity for Oligosaccharides and Sialic Acids and the Sequence to Which Sialic Acid Is Attached. J. Biol. Chem. 1986, 261, 17057-17061. (Pubitemid 17210357)
82. Markwell, M.; Svennerholm, L.; Paulson, J. Specific Gangliosides Function as Host Cell Receptors for Sendai Virus. Proc. Natl. Acad. Sci. 1981, 78, 5406-5410. (Pubitemid 12248595)
83. Rolsma, M.; Kuhlenschmidt, T.; Gelberg, H.; Kuhlenschmidt, M. Structure and Function of a Ganglioside Receptor for Porcine Rotavirus. J. Virol. 1998, 72, 9079-9091. (Pubitemid 28471852)
84. Superti, F.; Hauttecoeur, B.; Morelec, M.; Goldoni, P.; Bizzini, B.; Tsiang, H. Involvement of Gangliosides in Rabies Virus Infection. J. Gen. Virol. 1986, 67, 47-56. (Pubitemid 16177179)
85. Tsai, B.; Gilbert, J.; Stehle, T.; Lencer, W.; Benjamin, T.; Rapoport, T. Gangliosides Are Receptors for Murine Polyoma Virus and SV40. EMBO J. 2003, 22, 4346-4355. (Pubitemid 37087189)
86. Dewailly, P.; Decoopman, E.; Desreumaux, C.; Fruchart, J. Plasma Removal of Intravenous Essential Phospholipids in Man. Phosphatidylcholine: Biochem. Clin. Aspects Essent. Phospholipids 1976, 80-92.
87. Ulrich, A. Biophysical Aspects of Using Liposomes as Delivery Vehicles. Biosci. Rep. 2002, 22, 129-150. (Pubitemid 35222729)
88. Mourez, M.; Kane, R.; Mogridge, J.; Metallo, S.; Deschatelets, P.; Sellman, B.; Whitesides, G.; Collier, R. Designing a Polyvalent Inhibitor of Anthrax Toxin. Nat. Biotechnol. 2001, 19, 958-961. (Pubitemid 32947575)
89. Pan, J.; Charych, D. Molecular Recognition and Colorimetric Detection of Cholera Toxin by Poly(diacetylene) Liposomes Incorporating GM1 Ganglioside. Langmuir 1997, 13, 1365-1367. (Pubitemid 127557821)
90. Dhal, P.; Huval, C.; Holmes-Farley, S. Functional Polymers as Human Therapeutic Agents. Ind. Eng. Chem. Res. 2005, 44, 8593-8604. (Pubitemid 41729324)
91. Brekke, O.; Sandlie, I. Therapeutic Antibodies for Human Diseases at the Dawn of the 21st Century. Nat. Rev. Drug Discovery 2003, 2, 52-62. (Pubitemid 37361624)
92. Kitov, P.; Sadowska, J.; Mulvey, G.; Armstrong, G.; Ling, H.; Pannu, N.; Read, R.; Bundle, D. Shiga-like Toxins Are Neutralized by Tailored Multivalent Carbohydrate Ligands. Nature 2000, 403, 669-672. (Pubitemid 30104009)
93. Lauer, S.; Goldstein, B.; Nolan, R. L.; Nolan, J. P. Analysis of Cholera Toxin-Ganglioside Interactions by Flow Cytometry. Biochemistry 2002, 41, 1742-1751. (Pubitemid 34132248)
94. Nakashima, T.; Kobayashi, Y.; Yamasaki, S.; Kawakami, A.; Eguchi, K.; Sasaki, H.; Sakai, H. Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-B Ligand: Modulation of the Expression by Osteotropic Factors and Cytokines. Biochem. Biophys. Res. Commun. 2000, 275, 768-775.
95. Reig, N.; van der Goot, F. About Lipids and Toxins. FEBS Lett. 2006, 580, 5572-5579. (Pubitemid 44465906)
96. Wenk, M. Lipidomics of Host-Pathogen Interactions. FEBS Lett. 2006, 580, 5541-5551. (Pubitemid 44465899)
97. Casas, A.; Hubsch, A.; Doran, J. Effects of Reconstituted High-Density Lipoprotein in Persistent Gram-Negative Bacteremia. Am. Surgeon 1996, 62, 350-355.
98. McDonald, M.; Dhadly, P.; Cockerill, G.; Cuzzocrea, S.; Mota-Filipe, H.; Hinds, C.; Miller, N.; Thiemermann, C. Reconstituted High-Density Lipoprotein Attenuates Organ Injury and Adhesion Molecule Expression in a Rodent Model of Endotoxic Shock. Shock 2003, 20, 551-557.
99. Pajkrt, D.; Doran, J.; Koster, F.; Lerch, P.; Arnet, B.; Van der Poll, T.; Ten Cate, J.; Van Deventer, S. Antiinflammatory Effects of Reconstituted High-Density Lipoprotein During Human Endotoxemia. J. Exp. Med. 1996, 184, 1601-1608. (Pubitemid 26404453)
100. Parker, T.; Levine, D.; Chang, J.; Laxer, J.; Coffin, C.; Rubin, A. Reconstituted High-Density Lipoprotein Neutralizes Gram-Negative Bacterial Lipopolysaccharides in Human Whole Blood. Infect. Immun. 1995, 63, 253-258.
101. Bhattacharya, P.; Grimme, S.; Ganesh, B.; Gopisetty, A.; Sheng, J.; Martinez, O.; Jayarama, S.; Artinger, M.; Meriggioli, M.; Prabhakar, B. Nanodisc-Incorporated Hemagglutinin Provides Protective Immunity against Influenza Virus Infection. Jo. Virol. 2010, 84, 361-371.
102. Fischer, N.; Infante, E.; Ishikawa, T.; Blanchette, C.; Bourne, N.; Hoeprich, P.; Mason, P. Conjugation to Nickel-Chelating Nanolipoprotein Particles Increases the Potency and Efficacy of Subunit Vaccines To Prevent West Nile Encephalitis. Bioconjugate Chem. 2010, 21, 1018-1022.
103. McConathy, W.; Nair, M.; Paranjape, S.; Mooberry, L.; Lacko, A. Evaluation of Synthetic/Reconstituted High-Density Lipoproteins as Delivery Vehicles for Paclitaxel. Anti-cancer Drugs 2008, 19, 183-188.
104. Zhang, X.; Chen, B. Recombinant High Density Lipoprotein Reconstituted with Apolipoprotein AI Cysteine Mutants as Delivery Vehicles for 10-Hydroxycamptothecin. Cancer Lett. 2010, 298, 26-33.
105. Zhang, W. L.; Gu, X.; Bai, H.; Yang, R. H.; Dong, C. D.; Liu, J. P. Nanostructured Lipid Carriers Constituted from High-Density Lipoprotein Components for Delivery of a Lipophilic Cardiovascular Drug. Int. J. Pharm. 2010, 391, 313-321.
106. de Vrueh, R. L.; Rump, E. T.; van De Bilt, E.; van Veghel, R.; Balzarini, J.; Biessen, E. A.; van Berkel, T. J.; Bijsterbosch, M. K. Carrier-Mediated Delivery of 9-(2-Phosphonylmethoxyethyl) Adenine to Parenchymal Liver Cells: A Novel Therapeutic Approach for Hepatitis B. Antimicrob. Agents Chemother. 2000, 44, 477-483. (Pubitemid 30117929)
107. Parker, N.; Turk, M.; Westrick, E.; Lewis, J.; Low, P.; Leamon, C. Folate Receptor Expression in Carcinomas and Normal Tissues Determined by a Quantitative Radioligand Binding Assay. Anal. Biochem. 2005, 338, 284-293. (Pubitemid 40312593)
108. Zheng, G.; Chen, J.; Li, H.; Glickson, J. Rerouting Lipoprotein Nanoparticles to Selected Alternate Receptors for the Targeted Delivery of Cancer Diagnostic and Therapeutic Agents. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17757-17762. (Pubitemid 41803570)
109. Kader, A.; Pater, A. Loading Anticancer Drugs into HDL as Well as LDL Has Little Affect on Properties of Complexes and Enhances Cytotoxicity to Human Carcinoma Cells. J. Controlled Release 2002, 80, 29-44. (Pubitemid 34273746)
110. Neslihan Gursoy, R.; Benita, S. Self-Emulsifying Drug Delivery Systems (SEDDS) for Improved Oral Delivery of Lipophilic Drugs. Biomed. Pharmacother. 2004, 58, 173-182. (Pubitemid 38479922)
111. Martins, S.; Sarmento, B.; Ferreira, D.; Souto, E. Lipid-Based Colloidal Carriers for Peptide and Protein Delivery-Liposomes versus Lipid Nanoparticles. Int. J. Nanomed. 2007, 2, 595-607.
112. Puri, A.; Loomis, K.; Smith, B.; Lee, J.; Yavlovich, A.; Heldman, E.; Blumenthal, R. Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic. Crit. Rev. Ther. Drug Carrier Systems 2009, 26, 523-580.
113. Feng, M.; Cai, Q.; Shi, X.; Huang, H.; Zhou, P.; Guo, X. Recombinant High-Density Lipoprotein Complex as a Targeting System of Nosiheptide to Liver Cells. J. Drug Target. 2008, 16, 502-508. (Pubitemid 352015819)
114. Feng, M.; Cai, Q.; Huang, H.; Zhou, P. Liver Targeting and Anti-HBV Activity of Reconstituted HDL-Acyclovir Palmitate Complex. Eur. J. Pharm. Biopharm. 2008, 68, 688-693. (Pubitemid 351318196)
115. Nelson, K.; Bishop, J.; Ryan, R.; Titus, R. Nanodisk-Associated Amphotericin B Clears Leishmania Major Cutaneous Infection in Susceptible Balb/C Mice. Antimicrob. Agents Chemother. 2006, 50, 1238-1244.
116. Lou, B.; Liao, X.; Wu, M.; Cheng, P.; Yin, C.; Fei, Z. High-Density Lipoprotein as a Potential Carrier for Delivery of a Lipophilic Antitumoral Drug into Hepatoma Cells. World J. Gastroenterol. 2005, 11, 954-959. (Pubitemid 40347744)
117. Frias, M.; Lang, U.; Gerber-Wicht, C.; James, R. Native and Reconstituted HDL Protect Cardiomyocytes from Doxorubicin-Induced Apoptosis. Cardiovasc. Res. 2009, 2009, 1-9.
118. Besler, C.; Heinrich, K.; Riwanto, M.; Luscher, T. F.; Landmesser, U. High-Density Lipoprotein-Mediated Antiatherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease. Curr. Pharm. Des. 2010, 16, 1480-1493.
119. Spillmann, F.; Schultheiss, H. P.; Tschope, C.; Van Linthout, S. High-Density Lipoprotein-Raising Strategies: Update 2010. Curr. Pharm. Des. 2010, 16, 1517-1530.
120. Vaisar, T.; Mayer, P.; Nilsson, E.; Zhao, X.-Q.; Knopp, R.; Prazen, B. J. HDL in Humans with Cardiovascular Disease Exhibits a Proteomic Signature. Clin. Chim. Acta 2010, 411, 972-979.
121. Patel, S.; Drew, B.; Nakhla, S.; Duffy, S.; Murphy, A.; Barter, P.; Rye, K.; Chin-Dusting, J.; Hoang, A.; Sviridov, D. Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-inflammatory Properties and Cholesterol Efflux Capacity in Patients with Type 2 Diabetes. J. Am. Coll. Cardiol. 2009, 53, 962-971.
122. Shaw, J. A.; Bobik, A.; Murphy, A.; Kanellakis, P.; Blombery, P.; Mukhamedova, N.; Woollard, K.; Lyon, S.; Sviridov, D.; Dart, A. M. Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque. Circ. Res. 2008, 103, 1084-1091.
123. Tardif, J.; Heinonen, T.; Noble, S. High-Density Lipoprotein/ Apolipoprotein AI Infusion Therapy. Curr. Atheroscler. Rep. 2009, 11, 58-63.
124. Kruit, J.; Brunham, L.; Verchere, C.; Hayden, M. HDL and LDL Cholesterol Significantly Influence [β]-Cell Function in Type 2 Diabetes Mellitus. Curr. Opin. Lipidol. 2010, 21, 178-185.
125. Calkin, A. C.; Drew, B. G.; Ono, A.; Duffy, S. J.; Gordon, M. V.; Schoenwaelder, S. M.; Sviridov, D.; Cooper, M. E.; Kingwell, B. A.; Jackson, S. P. Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals with Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux. Circulation 2009, 120, 2095-2104.
126. Drew, B. G.; Duffy, S. J.; Formosa, M. F.; Natoli, A. K.; Henstridge, D. C.; Penfold, S. A.; Thomas, W. G.; Mukhamedova, N.; de Courten, B.; Forbes, J. M. High-Density Lipoprotein Modulates Glucose Metabolism in Patients with Type 2 Diabetes Mellitus. Circulation 2009, 119, 2103-2111.
127. Nieuwdorp, M.; Vergeer, M.; Bisoendial, R. J.; op't Roodt, J.; Levels, H.; Birjmohun, R. S.; Kuivenhoven, J. A.; Basser, R.; Rabelink, T. J.; Kastelein, J. J.; et al. Reconstituted Hdl Infusion Restores Endothelial Function in Patients with Type 2 Diabetes Mellitus. Diabetologia 2008, 51, 1081-1084.
128. van Oostrom, O.; Nieuwdorp, M.; Westerweel, P. E.; Hoefer, I. E.; Basser, R.; Stroes, E. S.; Verhaar, M. C. Reconstituted HDL Increases Circulating Endothelial Progenitor Cells in Patients with Type 2 Diabetes. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1864-1865. (Pubitemid 47207184)
129. Hardy, J.; Selkoe, D. J. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics. Science 2002, 297, 353-356. (Pubitemid 34790756)
130. Paula-Lima, A. C.; Tricerri, M. A.; Brito-Moreira, J.; Bomfim, T. R.; Oliveira, F. F.; Magdesian, M. H.; Grinberg, L. T.; Panizzutti, R.; Ferreira, S. T. Human Apolipoprotein A-I Binds Amyloid-[β] and Prevents a[β]-Induced Neurotoxicity. Int. J. Biochem. Cell Biol. 2009, 41, 1361-1370.
131. Navab, M.; Shechter, I.; Anantharamaiah, G.; Reddy, S.; Van Lenten, B.; Fogelman, A. Structure and Function of HDL Mimetics. Arterioscler., Thromb., Vasc. Biol. 2010, 30, 164-168.
132. Handattu, S.; Garber, D.; Monroe, C.; van Groen, T.; Kadish, I.; Nayyar, G.; Cao, D.; Palgunachari, M.; Li, L.; Anantharamaiah, G. Oral Apolipoprotein AI Mimetic Peptide Improves Cognitive Function and Reduces Amyloid Burden in a Mouse Model of Alzheimer's Disease. Neurobiol. Dis. 2009, 34, 525-534.
133. Balazs, Z.; Panzenboeck, U.; Hammer, A.; Sovic, A.; Quehenberger, O.; Malle, E.; Sattler, W. Uptake and Transport of High Density Lipoprotein (HDL) and HDL Associated Tocopherol by an in Vitro Blood-Brain Barrier Model. J. Neurochem. 2004, 89, 939-950. (Pubitemid 38684741)
134. Perrault, S. D.; Chan, W. C. W. In Vivo Assembly of Nanoparticle Components to Improve Targeted Cancer Imaging. Proc. Natl. Acad. Sci. 2010, 107, 11194-11199.
135. Liu, H.-L.; Hua, M.-Y.; Yang, H.-W.; Huang, C.-Y.; Chu, P.-C.; Wu, J.-S.; Tseng, I.-C.; Wang, J.-J.; Yen, T.-C.; Chen, P.-Y.; et al. Magnetic Resonance Monitoring of Focused Ultrasound/Magnetic Nanoparticle Targeting Delivery of Therapeutic Agents to the Brain. Proc. Natl. Acad. Sci. 2010, 107, 15205-15210.
136. Chen, W.; Jarzyna, P.; van Tilborg, G.; Nguyen, V.; Cormode, D.; Klink, A.; Griffioen, A.; Randolph, G.; Fisher, E.; Mulder, W. RGD Peptide Functionalized and Reconstituted High-Density Lipoprotein Nanoparticles as a Versatile and Multimodal Tumor Targeting Molecular Imaging Probe. FASEB J. 2010, 24, 1689.
137. Skajaa, T.; Cormode, D.; Falk, E.; Mulder, W.; Fisher, E.; Fayad, Z. High-Density Lipoprotein-Based Contrast Agents for Multimodal Imaging of Atherosclerosis. Arterioscler., Thromb., Vasc. Biol. 2010, 30, 169-176.
138. Corbin, I.; Chen, J.; Cao, W.; Li, H.; Lund-Katz, S.; Zheng, G. Enhanced Cancer-Targeted Delivery Using Engineered High-Density Lipoprotein-Based Nanocarriers. J. Biomed. Nanotechnol. 2007, 3, 367-376. (Pubitemid 351877140)